Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis.
Huijing DongChongxiang XueYumin ZhengXu ZhangZixin HuXingyu LuYixuan YuJia LiKexin TanHuijuan CuiPublished in: Journal of oncology (2023)
According to this meta-analysis, ICIs are effective and safe for patients with hepatitis B or C, but basic liver enzymes have to be evaluated before treatment to avoid liver adverse events.